Simplex Trading
CRDF icon

Simplex Trading’s Cardiff Oncology CRDF Stock Holding History

Simplex Trading’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$95.3K Sell
58,800
-46,700
-44% -$95.9K ﹤0.01% 5141
2025
Q4 		$296K Buy
105,500
+53,600
+103% +$124K ﹤0.01% 3825
2025
Q3 		$106K Sell
51,900
-79,800
-61% -$221K ﹤0.01% 5664
2025
Q2 		$414K Buy
131,700
+115,600
+718% +$353K ﹤0.01% 3712
2025
Q1 		$50K Sell
16,100
-92,400
-85% -$365K ﹤0.01% 5768
2024
Q4 		$470K Buy
108,500
+103,600
+2,114% +$324K ﹤0.01% 3609
2024
Q3 		$13K Buy
4,900
+3,500
+250% +$8.27K ﹤0.01% 6993
2024
Q2 		$3K Sell
1,400
-21,400
-94% -$80.7K ﹤0.01% 8091
2024
Q1 		$121K Buy
22,800
+21,500
+1,654% +$57.1K ﹤0.01% 5391
2023
Q4 		$1K Sell
1,300
-4,100
-76% -$4.96K ﹤0.01% 8452
2023
Q3 		$7K Sell
5,400
-7,300
-57% -$12.3K ﹤0.01% 7403
2023
Q2 		$18K Sell
12,700
-1,000
-7% -$1.61K ﹤0.01% 6866
2023
Q1 		$22K Buy
13,700
+12,300
+879% +$21.1K ﹤0.01% 6808
2022
Q4 		$1K Sell
1,400
-76,300
-98% -$109K ﹤0.01% 8784
2022
Q3 		$119K Buy
77,700
+69,900
+896% +$168K ﹤0.01% 5273
2022
Q2 		$17K Buy
7,800
+5,800
+290% +$9.71K ﹤0.01% 7760
2022
Q1 		$4K Sell
2,000
-13,400
-87% -$47.4K ﹤0.01% 9529
2021
Q4 		$92K Sell
15,400
-86,500
-85% -$516K ﹤0.01% 6394
2021
Q3 		$677K Hold
101,900
– – ﹤0.01% 3665
2021
Q2 		$677K Buy
101,900
+101,473
+23,764% +$861K ﹤0.01% 3705
2021
Q1 		$395K Sell
427
-289
-40% -$3.51K ﹤0.01% 3722
2020
Q4 		$1.29M Sell
716
-96
-12% -$1.69K ﹤0.01% 2234
2020
Q3 		$1.15M Buy
+812
New +$5.36K ﹤0.01% 2063

Other funds holding CRDF

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $6.71B AUM 23.99% 1-Year Est. Return

Simplex Trading's CRDF Position: Q1 2026 in Review

Simplex Trading opened a new position in Cardiff Oncology (CRDF) in Q1 2026: 16,454 shares worth $26.7K. The stake represents ﹤0.01% of the portfolio and ranks #6510 among its holdings. This is a return to the name: Simplex Trading previously reported a position in CRDF as recently as Q3 2025.

Simplex Trading first reported a position in CRDF in Q4 2015 and has held it in 25 quarters since. The position peaked at $387K in Q1 2025. 116 funds tracked by Wall St. Rank hold CRDF as of Q1 2026.

  • Simplex Trading held 16,454 shares of Cardiff Oncology worth $26.7K as of Q1 2026.
  • Cardiff Oncology was a new Simplex Trading position in Q1 2026.
  • Cardiff Oncology made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #6510 holding.
  • Simplex Trading first reported a position in Cardiff Oncology in Q4 2015 and has held it in 25 quarters since.
  • Simplex Trading's Cardiff Oncology position peaked at $387K in Q1 2025.
  • 116 funds tracked by Wall St. Rank held Cardiff Oncology as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.